Skip to Content

Fasenra Side Effects

Generic Name: benralizumab

Note: This document contains side effect information about benralizumab. Some of the dosage forms listed on this page may not apply to the brand name Fasenra.

For the Consumer

Applies to benralizumab: subcutaneous solution

Along with its needed effects, benralizumab (the active ingredient contained in Fasenra) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking benralizumab:

Less Common

  • Fast heartbeat
  • fever
  • hives, itching, or skin rash
  • hoarseness
  • irritation
  • joint pain, stiffness, or swelling
  • redness of the skin
  • swelling of the eyelids, face, lips, hands, or feet
  • tightness in the chest
  • troubled breathing or swallowing

Some side effects of benralizumab may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More Common

Less Common

  • Bleeding, blistering, burning, coldness, discoloration of skin, feeling of pressure, hives, infection, inflammation, itching, lumps, numbness, pain, rash, redness, scarring, soreness, stinging, swelling, tenderness, tingling, ulceration, or warmth at the injection site
  • body aches or pain
  • congestion
  • cough
  • dryness or soreness of the throat
  • runny nose
  • tender, swollen glands in the neck
  • voice changes

For Healthcare Professionals

Applies to benralizumab: subcutaneous solution

Hypersensitivity

Frequency not reported: Anaphylaxis, angioedema[Ref]

Immunologic

Frequency not reported: Immunogenicity[Ref]

Local

Common (1% to 10%): Injection site reactions (e.g., pain, erythema, pruritus, papule)[Ref]

Respiratory

Common (1% to 10%): Pharyngitis (bacterial, viral, or streptococcal), cough[Ref]

Other

Common (1% to 10%): Pyrexia[Ref]

Nervous system

Common (1% to 10%): Headache[Ref]

Dermatologic

Common (1% to 10%): Urticaria, rash[Ref]

References

1. "Product Information. Fasenra (benralizumab)." Astra-Zeneca Pharmaceuticals, Wilmington, DE.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Hide